Skip to search formSkip to main contentSkip to account menu

ANKRD30A gene

Known as: NY-BR-1, ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 30A, ANKRD30A 
This gene may play a role in breast-specific transcription.
National Institutes of Health

Related topics

Related topics

5 relations

Narrower (1)

ANKRD30A wt Allele
Breast Cancer Antigen NY-BR-1 ProteinBreast CarcinomaImmune response

Broader (1)

Genes

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Abstract B054: Evaluation of NY-BR-1 as a suitable antigen for CAR based immunotherapy
Despite the tremendous clinical success of CAR-T-cell therapy in leukemia, translation of this treatment option to solid tumors… 
2016
2016
Abstract LB-378: Ankyrin repeat domain 30A as a novel molecular marker of columnar alterations in benign breast disease and subsequent breast cancer in African American women
An estimated 1.6 million breast biopsies are performed annually in the United States, and the vast majority are benign. Benign… 
2015
2015
NY-BR-1 Antigen Expression and anti-NY-BR-1 IgG in Egyptian Breast Cancer Patients: Clinicopathological and Prognostic Significance.
Breast cancer is the most common gynecological malignancy in the world. In Egypt, it ranks the first among female malignancies… 
2014
2014
Abstract 3284: Genome-wide association study identifies new susceptibility loci of epithelial ovarian cancer in Han Chinese
Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CA Ovarian cancer is the leading cause of cancer death of… 
2013
2013
Cancer testis antigens and NY-BR-1 expression in primary breast cancer: prognostic and therapeutic implications
Cancer–testis antigens (CTA) comprise a family of proteins, which are physiologically expressed in adult human tissues solely in… 
2013
2013
Abstract 1259: Murine HLA-restricted CD4+ T cell lines as source of high affinity TCRs specific for the human breast cancer-associated tumor antigen NY-BR-1.
Proceedings: AACR 104th Annual Meeting 2013; Apr 6-10, 2013; Washington, DC Out of all malignancies, breast cancer is the second… 
2012
2012
Abstract 1581: Identification of novel HLA-restricted T-cell epitopes specific for the breast cancer-associated tumor antigen NY-BR-1
Proceedings: AACR 103rd Annual Meeting 2012‐‐ Mar 31‐Apr 4, 2012; Chicago, IL Out of all malignancies, breast cancer resembles… 
Review
2009
Review
2009
A Survey of NY-BR-1 Immunohistochemistry in Breast, Ovarian, Endometrial and Lung Cancers: A Correlation Study with Estrogen and Progesterone Receptors.
Background: Estrogen and progesterone hormone receptors are expressed in a majority of breast cancers. Therefore they are… 
2007
2007
Radiographic techniques for medical-dental research with minipigs.
2004
2004
The breast differentiation antigen NY-BR-1: A novel target antigen for active immunotherapy in breast cancer.
2575 Background: There is evidence that the immune system interacts with cancer cells. This interaction influences the… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)